| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10965286 | Vaccine | 2014 | 8 Pages |
Abstract
Effectiveness of two-dose monovalent rotavirus vaccine in preventing hospital admission with rotavirus diarrhea was high, lasted for two years and it was similar against both G1P[8] and G2P[4]. Based on the findings of the study we recommend the continued use of rotavirus in the Brazilian National Immunization Program and the monitoring of the early emergence of unusual and novel rotavirus genotypes.
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Maria Y.T. Ichihara, Laura C. Rodrigues, Carlos A.S. Teles Santos, Maria da Gloria L.C. Teixeira, Sandra R. De Jesus, Sheila M. Alvim De Matos, Jose P. Gagliardi Leite, Mauricio L. Barreto,